Category: St. Jude MedicalSyndicate content

St. Jude launches Prodigy spinal cord stimulator in Canada

May 20, 2015 by Fink Densford

St. Jude Medical says it won Health Canada approval and implanted its 1st Prodigy spinal cord stimulator north of the border.

St. Jude launches Prodigy spinal cord stimulator in Canada

HRS 2015: Study recommends case-by-case eval of recalled Riata defib leads

May 15, 2015 by Fink Densford

A Canadian study of patients implanted with St. Jude Medical's recalled Riata leads concludes that extraction and revision should be handled on a case-by-case basis.

HRS 2015: Study recommends case-by-case eval of recalled Riata defib leads

HRS 2015: Remote cardiac monitoring cuts hospital visits, healthcare costs

May 14, 2015 by Fink Densford

Data from a new, 5-year study shows that remote cardiac monitoring helps improve care and lower healthcare costs.

HRS 2015: Study of CRM remote monitoring reports decrease in hospital visits, hospital costs.

St. Jude Medical expands CE Mark approval for Ellipse ICD

May 13, 2015 by Fink Densford

St. Jude Medical announces expanded CE Mark approval in the European Union for its high-voltage Ellipse implantable cardioverter defibrillator.

St. Jude Medical Expands CE Mark Approval for ICD Device.

CEO says SNN 'working hard' on acquisitions trail | The week in medtech M&A

May 6, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Smith & Nephew 'working hard' on acquisitions trail, CEO says; Profound Medical goes public in reverse merger; Greatbatch mulls spinout for Algostim SCS business; Wright Medical delays Augment timeline; St. Jude Medical closes Spinal Modulation buy

Smith & Nephew 'working hard' on acquisitions trail, CEO says

April 30, 2015 by Brad Perriello

FDA approves STJ's MRI-safe SCS device | Regulatory news for the week of May 4, 2015

May 5, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA approves MRI-safe SCS device from St. Jude Medical; Surprise CE Mark for Stentys Xposition S stent; Wright Medical delays Augment timeline; FTC: We might force M&A divestitures in outside markets; FDA closes out CryoLife warning letter, PerClot trial launches

FDA approves MRI-safe SCS device from St. Jude Medical

April 30, 2015 by Brad Perriello

St. Jude Medical closes Spinal Modulation buy

May 4, 2015 by Brad Perriello

St. Jude Medical closes its $175 million buyout of Spinal Modulation as it expands its footprint in the neuromodulation space.

St. Jude Medical closes Spinal Modulation buy